Income Statement Redcare Pharmacy NV

Equities

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra Other stock markets 11:35:01 2025-01-24 am EST			5-day change	1st Jan Change
126.00 ^EUR	+2.94%		+5.62%	-4.33%

Jan. 15	REDCARE PHARMACY : Berenberg reiterates its Buy rating	ZD
Jan. 14	Redcare Pharmacy: Europe's leading online pharmacy secures its position

121be370dfcdce8420e.EiAmYAvg3fj3dSf-9V-eGAr6Ih1PPNUdv8NAxx5a99M.WU9qMmiBn5KELx6XzGbfcm2tbnAZT4p765MLnUo9gL9ZR2EDeM3sr6NBfg

Published financial data: REDCARE PHARMACY NV

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	701M	968M	1.06B	1.2B	1.8B
Total Revenues	701M	968M	1.06B	1.2B	1.8B
Cost of Goods Sold, Total	563M	749M	794M	873M	1.36B
Gross Profit	138M	220M	267M	332M	440M
Selling General & Admin Expenses, Total	172M	214M	299M	379M	444M
Other Operating Expenses	-136K	-65K	-160K	-149K	-318K
Other Operating Expenses, Total	172M	214M	298M	379M	444M
Operating Income	-34.04M	5.56M	-31.65M	-47.23M	-3.79M
Interest Expense, Total	-7.48M	-10.41M	-8.57M	-8.5M	-8M
Interest And Investment Income	1.22M	-	-	233K	4.6M
Net Interest Expenses	-6.26M	-10.41M	-8.57M	-8.27M	-3.39M
Income (Loss) On Equity Invest.	104K	45K	-427K	339K	226K
Currency Exchange Gains (Loss)	-28K	-234K	1.49M	1.76M	277K
Other Non Operating Income (Expenses)	-2.55M	-4.06M	-4.52M	-7.2M	-7.02M
EBT, Excl. Unusual Items	-42.78M	-9.11M	-43.68M	-60.6M	-13.7M
Merger & Related Restructuring Charges	600K	-	-600K	-323K	-
Gain (Loss) On Sale Of Investments	-	-398K	-156K	-1.58M	-
Other Unusual Items	-	-6.42M	-33.45M	-21.62M	-648K
EBT, Incl. Unusual Items	-42.18M	-15.93M	-77.88M	-84.12M	-14.35M
Income Tax Expense	-5.91M	839K	-3.7M	-6.47M	-2.74M
Earnings From Continuing Operations	-36.27M	-16.77M	-74.18M	-77.65M	-11.61M
Net Income to Company	-36.27M	-16.77M	-74.18M	-77.65M	-11.61M
Minority Interest	-	-	-	-	-435K
Net Income - (IS)	-36.27M	-16.77M	-74.18M	-77.65M	-12.04M
Net Income to Common Incl Extra Items	-36.27M	-16.77M	-74.18M	-77.65M	-12.04M
Net Income to Common Excl. Extra Items	-36.27M	-16.77M	-74.18M	-77.65M	-12.04M
Per Share Items
Net EPS - Basic	-2.78	-1.17	-4.15	-4.32	-0.63
Basic EPS - Continuing Operations	-2.78	-1.17	-4.15	-4.32	-0.63
Basic Weighted Average Shares Outstanding	13.06M	14.38M	17.88M	17.98M	19.24M
Net EPS - Diluted	-2.78	-1.17	-4.15	-4.32	-0.63
Diluted EPS - Continuing Operations	-2.78	-1.17	-4.15	-4.32	-0.63
Diluted Weighted Average Shares Outstanding	13.06M	14.38M	17.88M	17.98M	19.24M
Normalized Basic EPS	-2.05	-0.4	-1.53	-2.11	-0.47
Normalized Diluted EPS	-2.05	-0.4	-1.53	-2.11	-0.47
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-26.18M	12.8M	-21M	-34M	14.48M
EBITA	-27.87M	9.51M	-27.45M	-42.88M	4.72M
EBIT	-34.04M	5.56M	-31.65M	-47.23M	-3.79M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	14.01	-5.27	4.75	7.7	19.11
Total Current Taxes	-	397K	563K	-53K	978K
Total Deferred Taxes	-	442K	-4.26M	-6.42M	-3.72M
Normalized Net Income	-26.74M	-5.69M	-27.3M	-37.88M	-9M
Interest on Long-Term Debt	7.48M	10.23M	6.74M	7.16M	7.48M
Supplemental Operating Expense Items
Selling and Marketing Expenses	143M	186M	262M	332M	384M
General and Administrative Expenses	28.47M	28.44M	36.12M	46.81M	60.05M
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	2.97M	4.4M	20.54M	16.23M	9M
Total Stock-Based Compensation	2.97M	4.4M	20.54M	16.23M	9M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	62.65M	90.48M	247M	66.78M	84.16M
Short Term Investments	50.58M	37.77M	36.42M	118M	120M
Total Cash And Short Term Investments	113M	128M	284M	184M	204M
Accounts Receivable, Total	26.71M	29.98M	27.92M	30M	103M
Other Receivables	-	-	8.25M	10.94M	16.17M
Total Receivables	26.71M	29.98M	36.16M	40.95M	119M
Inventory	56.69M	81.24M	96.62M	99.71M	136M
Prepaid Expenses	5.68M	4.71M	3.7M	6.57M	10.89M
Other Current Assets, Total	8.5M	9.9M	12.45M	12.35M	29.38M
Total Current Assets	211M	254M	433M	344M	500M
Gross Property Plant And Equipment	21M	88.85M	96.24M	116M	112M
Accumulated Depreciation	-9.99M	-14.3M	-17.98M	-31.01M	-25.05M
Net Property Plant And Equipment	11.01M	74.54M	78.26M	85.44M	86.91M
Long-term Investments	4.02M	3.5M	1.47M	1.26M	1.31M
Goodwill	129M	129M	153M	170M	277M
Other Intangibles, Total	70.73M	75.54M	104M	119M	151M
Deferred Tax Assets Long-Term	120K	120K	-	462K	2.3M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	2.16M	-	13.11M	9.39M	3.46M
Total Assets	428M	537M	783M	729M	1.02B
Liabilities
Accounts Payable, Total	31.35M	51.32M	78.12M	68.94M	152M
Accrued Expenses, Total	9.78M	15.65M	36.38M	38.64M	56.79M
Short-term Borrowings	10.17M	39K	38K	40K	-
Current Portion of Long-Term Debt	5.26M	-	1.62M	1.62M	1.62M
Current Portion of Leases	2.26M	5.38M	4.74M	5.88M	7.14M
Current Income Taxes Payable	323K	390K	775K	241K	573K
Other Current Liabilities	653K	1.82M	2.41M	3.94M	5.6M
Total Current Liabilities	59.8M	74.61M	124M	119M	224M
Long-Term Debt	127M	4.08M	195M	200M	204M
Long-Term Leases	4.15M	28.73M	26.06M	27.59M	30.68M
Pension & Other Post Retirement Benefits	-	-	-	5.69M	4.5M
Deferred Tax Liability Non Current	3.9M	4.35M	13.55M	7.89M	6.32M
Other Non Current Liabilities	-	-	8.6M	14.62M	-
Total Liabilities	195M	112M	368M	375M	470M
Common Stock, Total	269K	354K	361K	362K	398K
Additional Paid In Capital	341M	552M	567M	571M	733M
Retained Earnings	-120M	-134M	-208M	-285M	-280M
Comprehensive Income and Other	11.8M	6.84M	56.3M	69M	68.3M
Total Common Equity	233M	425M	415M	355M	522M
Minority Interest	-	-	-	-	29.84M
Total Equity	233M	425M	415M	355M	552M
Total Liabilities And Equity	428M	537M	783M	729M	1.02B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.46M	17.94M	18.1M	18.2M	20.2M
ECS Total Common Shares Outstanding	13.46M	17.94M	18.1M	18.2M	20.2M
Book Value / Share	17.29	23.7	22.96	19.49	25.85
Tangible Book Value	32.91M	220M	158M	65.62M	94.09M
Tangible Book Value Per Share	2.44	12.29	8.73	3.61	4.66
Total Debt	149M	38.23M	228M	235M	244M
Net Debt	35.97M	-90.02M	-55.99M	50.56M	39.63M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	29.84M
Equity Method Investments, Total	1.51M	1.76M	1.46M	1.26M	1.3M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	-	-	478K	1.52M
Inventories - Finished Goods, Total	-	-	-	104M	139M
Land - (BS)	13.17M	40.95M	37.88M	48.19M	5.3M
Machinery, Total	181K	12.29M	35.25M	43.53M	49.74M
Full Time Employees	855	1.04K	1.34K	1.64K	1.72K
Part Time Employees	320	336	485	528	349
Accumulated Allowance for Doubtful Accounts (Supple)	3.02M	4.3M	4.69M	4.8M	5.08M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-36.27M	-16.77M	-74.18M	-77.65M	-12.04M
Depreciation & Amortization - CF	4.02M	5.82M	11.42M	13.83M	16.03M
Amortization of Goodwill and Intangible Assets - (CF)	6.18M	3.95M	4.2M	4.35M	8.5M
Depreciation & Amortization, Total	10.2M	9.77M	15.62M	18.19M	24.54M
Amortization of Deferred Charges, Total - (CF)	4.41M	6.29M	11.34M	21.32M	32.75M
(Gain) Loss From Sale Of Asset	-	-	-	-	140K
Asset Writedown & Restructuring Costs	257K	-	-	-	-
Stock-Based Compensation (CF)	2.97M	4.4M	20.54M	16.23M	9M
Other Operating Activities, Total	2.8M	15.34M	9.8M	9.78M	-6.42M
Change In Accounts Receivable	-7.31M	-3.7M	-6.58M	-2.28M	-20.32M
Change In Inventories	-13.34M	-24.55M	-15.38M	-3.08M	-16.6M
Change In Accounts Payable	5.93M	27.01M	26.51M	-12.24M	56.81M
Change in Other Net Operating Assets	-	-	23.97M	625K	-6.41M
Cash from Operations	-30.37M	17.8M	11.64M	-29.11M	61.46M
Capital Expenditure	-4M	-38.24M	-13.82M	-13.56M	-6.44M
Cash Acquisitions	-	-	-31.18M	-6.02M	-23.44M
Sale (Purchase) of Intangible assets	-10.74M	-15.1M	-29.34M	-39.96M	-31.78M
Investment in Marketable and Equity Securities, Total	-18.66M	13.08M	2.41M	-80.49M	-7.36M
Other Investing Activities, Total	-	-	-12.37M	2.02M	9.06M
Cash from Investing	-33.4M	-40.26M	-84.3M	-138M	-59.96M
Short Term Debt Issued, Total	-	-	-	2K	-
Long-Term Debt Issued, Total	58.59M	-	235M	-	-
Total Debt Issued	58.59M	-	235M	2K	-
Short Term Debt Repaid, Total	-	-10.13M	-1K	-	-
Long-Term Debt Repaid, Total	-2.46M	-2.36M	-11.45M	-7.09M	-8.97M
Total Debt Repaid	-2.46M	-12.49M	-11.45M	-7.09M	-8.97M
Issuance of Common Stock	49.15M	75.74M	12.22M	637K	32.04M
Other Financing Activities, Total	-3.2M	-12.96M	-6.38M	-7.07M	-8.02M
Cash from Financing	102M	50.29M	230M	-13.52M	15.05M
Foreign Exchange Rate Adjustments	-	-	-	-	844K
Miscellaneous Cash Flow Adjustments	-	1K	-	-	-
Net Change in Cash	38.31M	27.83M	157M	-181M	17.38M
Supplemental Items
Cash Interest Paid	7.4M	13.02M	6.38M	7.07M	8.02M
Cash Income Tax Paid (Refund)	-	-	179K	457K	1.44M
Levered Free Cash Flow	-38.03M	-37.07M	4.6M	-49.19M	-7.65M
Unlevered Free Cash Flow	-33.36M	-30.56M	9.95M	-43.88M	-2.65M
Change In Net Working Capital	14.91M	1.17M	-25.38M	16.57M	28.35M
Net Debt Issued / Repaid	56.14M	-12.49M	224M	-7.08M	-8.97M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-5.47	0.72	-3	-3.9	-0.27
Return on Total Capital	-6.22	0.82	-3.58	-4.79	-0.34
Return On Equity %	-16.24	-5.1	-17.65	-20.17	-2.56
Return on Common Equity	-16.24	-5.1	-17.65	-20.17	-2.75
Margin Analysis
Gross Profit Margin %	19.64	22.68	25.16	27.55	24.48
SG&A Margin	24.52	22.11	28.16	31.48	24.71
EBITDA Margin %	-3.73	1.32	-1.98	-2.82	0.8
EBITA Margin %	-3.98	0.98	-2.59	-3.56	0.26
EBIT Margin %	-4.86	0.57	-2.98	-3.92	-0.21
Income From Continuing Operations Margin %	-5.17	-1.73	-7	-6.45	-0.65
Net Income Margin %	-5.17	-1.73	-7	-6.45	-0.67
Net Avail. For Common Margin %	-5.17	-1.73	-7	-6.45	-0.67
Normalized Net Income Margin	-3.81	-0.59	-2.57	-3.14	-0.5
Levered Free Cash Flow Margin	-5.43	-3.83	0.43	-4.08	-0.43
Unlevered Free Cash Flow Margin	-4.76	-3.16	0.94	-3.64	-0.15
Asset Turnover
Asset Turnover	1.8	2.01	1.61	1.59	2.05
Fixed Assets Turnover	61.12	22.07	13.88	14.71	20.87
Receivables Turnover (Average Receivables)	28.75	34.15	36.63	41.59	27.02
Inventory Turnover (Average Inventory)	11.26	10.85	8.92	8.89	11.54
Short Term Liquidity
Current Ratio	3.53	3.41	3.49	2.88	2.23
Quick Ratio	2.34	2.12	2.58	1.89	1.45
Operating Cash Flow to Current Liabilities	-0.51	0.24	0.09	-0.24	0.27
Days Sales Outstanding (Average Receivables)	12.7	10.72	9.96	8.78	13.51
Days Outstanding Inventory (Average Inventory)	32.41	33.72	40.91	41.06	31.64
Average Days Payable Outstanding	18.18	19.57	29.2	30.65	28.92
Cash Conversion Cycle (Average Days)	26.93	24.87	21.67	19.19	16.23
Long Term Solvency
Total Debt/Equity	64.1	8.99	54.85	66.24	44.16
Total Debt / Total Capital	39.06	8.25	35.42	39.84	30.63
LT Debt/Equity	56.5	7.72	53.3	64.11	42.57
Long-Term Debt / Total Capital	34.43	7.08	34.42	38.56	29.53
Total Liabilities / Total Assets	45.61	20.82	46.95	51.39	45.96
EBIT / Interest Expense	-4.55	0.53	-3.69	-5.55	-0.47
EBITDA / Interest Expense	-3.19	1.47	-1.87	-3.42	2.59
(EBITDA - Capex) / Interest Expense	-3.72	-2.2	-3.48	-5.01	1.79
Total Debt / EBITDA	-6.26	2.49	-14.22	-8.09	11.75
Net Debt / EBITDA	-1.51	-5.87	3.49	-1.74	1.91
Total Debt / (EBITDA - Capex)	-5.36	-1.67	-7.63	-5.51	17.03
Net Debt / (EBITDA - Capex)	-1.29	3.93	1.88	-1.19	2.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	29.89	38.1	9.53	13.58	49.35
Gross Profit, 1 Yr. Growth %	38.63	59.19	21.53	24.36	32.73
EBITDA, 1 Yr. Growth %	29.36	-162.21	-264.06	57.46	-142.58
EBITA, 1 Yr. Growth %	28.87	-142.71	-388.71	52.87	-111
EBIT, 1 Yr. Growth %	23.03	-119.54	-669.55	46.45	-91.98
Earnings From Cont. Operations, 1 Yr. Growth %	7.92	-53.76	342.34	4.67	-85.05
Net Income, 1 Yr. Growth %	7.92	-53.76	342.34	4.67	-84.49
Normalized Net Income, 1 Yr. Growth %	27.58	-75.49	379.42	36.86	-76.25
Diluted EPS Before Extra, 1 Yr. Growth %	-0.49	-57.99	255.68	4.07	-85.51
Accounts Receivable, 1 Yr. Growth %	21.12	12.23	-6.87	7.47	243.73
Inventory, 1 Yr. Growth %	30.77	43.31	18.94	3.19	36.18
Net Property, Plant and Equip., 1 Yr. Growth %